HSCT with mismatched unrelated donors: Bone marrow versus peripheral blood stem cells sources in pediatric patients.

Despite all the limits of this retrospective study we were able to show how the combination of BM and ATG is able to prevent GvHDs and guarantee a high OS. Future studies addressing the issue of a post-transplant cellular therapy approach may potentially reduce relapses when GvHD is absent.